Drug Trial Radar · NCT04898283
Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
Last checked: Nov 20, 2026Latest source record: May 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
180
Planned (sponsor's estimate)
Start
May 31, 2021
Primary completion
Oct 2026
Study completion Oct 2026
Sponsor
- Lead sponsor
- Inmunotek S.L.Industry
- Sponsor type
- Industry
- First posted
- May 24, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 12 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Randomized, Double-Blinded, Placebo-Controlled, Prospective, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Subcutaneous Immunotherapy in Patients With Rhinitis/Rhinoconjunctivitis With or Without Mild to Moderate Asthma Sensitized to cupressaceae and grasses.
Conditions
- Rhinitis, Allergic
- Rhinoconjunctivitis
- Asthma, Allergic
Interventions
10,000 MG01 +10,000 T521Biological
Purified and polymerized with glutaraldehyde allergen extract, from a mixture of grasses (Phleum pratense, Holcus lanatus, Poa pratensis, Festuca pratensis, Lolium perenne and Dactylis glomerata) and cupressaceae (Juniperus oxycedrus), adsorbed on aluminum hydroxide. The other ingredients are: sodium chloride (0.9%), phenol (0.4%) and water for injections
30,000 MG01 +10,000 T521Biological
Purified allergen extract polymerized with glutaraldehyde, from a mixture of grasses (Phleum pratense, Holcus lanatus, Poa pratensis, Festuca pratensis, Lolium perenne and Dactylis glomerata) and cupressaceae (Juniperus oxycedrus), adsorbed on aluminum hydroxide. The other ingredients are: sodium chloride (0.9%), phenol (0.4%) and water for injections.
Placebo subcutaneousOther
The same solution and presentation as the active treatment, but without active ingredients
Primary outcomes
What the sponsor says the trial is designed to measure.
- RCSMS: Combined Symptoms and Medication Score of rhinitis. Combined symptom and medication score in rhinitis/rhinoconjunctivitis (RCSMS)Time frame: 18 months
Locations
27 sites in 1 country. Site status is shown where the registry gives one.
Hospital Nuestra Señora de Sonsoles
Ávila, Spain · Not yet recruiting
Fundación Hospital Sant Pere Claver
Barcelona, Spain · Withdrawn
Clínica privada Burgos
Burgos, Spain · Withdrawn
Hospital Universitario de Burgos
Burgos, Spain · Recruiting
Hospital General de Villalba
Collado Villalba, Spain · Not yet recruiting
Clinica privada
León, Spain · Withdrawn
Clínica Subiza
Madrid, Spain · Active not recruiting
Hospital Carlos III (antiguo CAP José Marva)
Madrid, Spain · Withdrawn
Clínica Privada
Madrid, Spain · Withdrawn
Hospital Universitario Ramón y Cajal
Madrid, Spain · Not yet recruiting
Hospital Universitario Fundación Jiménez Díaz
Madrid, Spain · Recruiting
Hospital Infanta Elena
Madrid, Spain · Not yet recruiting
Centro médico Saluddia
Madrid, Spain · Recruiting
Centro Médico Iza (Clínica Privada Madrid)
Madrid, Spain · Recruiting
Consulta Privada
Palencia, Spain · Completed
Hospital Clínico de Salamanca
Salamanca, Spain · Active not recruiting
Hospital General Universitario de Segovia
Segovia, Spain · Not yet recruiting
Clinica Privada Soria
Soria, Spain · Withdrawn
Clínica Privada
Zaragoza, Spain · Withdrawn
Hospital Recoletas Felipe Ii
Valladolid, Castille and León, Spain · Recruiting
Cedt de Tarancón
Tarancón, Cuenca, Spain · Recruiting
Hospital Universitario Principe de Asturias
Alcalá de Henares, Madrid, Spain · Completed
Hospital U. Fundación Alcorcón
Alcorcón, Madrid, Spain · Recruiting
Hospital Cruz Roja Madrid
Madrid, Madrid, Spain · Recruiting
Clínica Privada Dres Ojeda
Madrid, Madrid, Spain · Recruiting
Hospital Universitario Puerta de Hierro
Majadahonda, Madrid, Spain · Not yet recruiting
Clínica Privada Murcia
Murcia, Murcia, Spain · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.